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Introduction 
Median sternotomy (MS) is the gold standard 
approach for surgical treatment of cardiac 
diseases with proven excellent long-term 
outcomes [1]; however, it carries the risk of deep 
sternal wound infection, delayed recovery, and 
increased hospital stay [2]. A variety of minimally 
invasive techniques have been developed, 
including right thoracotomy, to improve the 
functional and cosmetic outcomes [3].  
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Abstract 
Background: The advantages of the right anterolateral thoracotomy (RALT) 
approach for mitral valve surgery over standard median sternotomy (MS) are still 
debatable. The objective of this study was to evaluate and compare the 
postoperative clinical outcome after RALT and MS for mitral valve replacement. 
Methods: This prospective observational study included 40 patients who 
underwent mitral valve replacement between January 2016 and August 2018. 
Patients were assigned to two groups, the first group included 20 patients who had 
conventional median sternotomy approach and the second group included 20 
patients who had right anterolateral thoracotomy with the complete cannulation 
and aortic cross-clamping conducted through the same incision. 
Results: In comparison to MS, RALT had significantly higher cross-clamp time 
(77.7±16.1 vs 45.8±8.7 minutes, P < 0.01), total bypass time (105.2±12.7 vs 
72.2±10.4 minutes, P < 0.01), and total operative time (287±41 vs 231±36 min, P < 
0.01), in addition to significantly lower ventilation time (4.2±1.51 vs 6.1±1.84 hours, 
P < 0.01), blood loss (229±85 vs 335±137 ml), amount of blood transfusion (1.41±0.6 
vs 2.19±1.1 units, P < 0.01), ICU stay duration (2.11±0.49 vs 2.78±0.82 days, P < 
0.01), pain scores at 1st and 2nd postoperative days (5.67±0.79 vs 7.81±0.53, p < 
0.01), and total hospital stay duration (7.2±1.3 vs 8.4±1.6 days, P = 0.01). Patients' 
satisfaction about their wound was significantly higher in RALT group compared to 
MS group (95% vs 30%, P < 0.01). 
Conclusion: The RALT approach for mitral valve surgery could be a safe and effective 
approach when compared to median sternotomy. RALT could be associated with a 
reduction of blood loss, blood transfusion, wound infection, in addition to shorter 
ICU and hospital stay. 
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Less invasive approaches for mitral valve 
surgery can offer certain advantages over MS, 
notably reduced surgical trauma [4], reduced 
postoperative discomfort, low perioperative 
morbidity [5], low rates of reoperation [6], 
decreased postoperative recovery time, increased 
patient satisfaction, and reduced cost [7, 8].  
Right anterolateral thoracotomy (RALT) is a 
less invasive approach for mitral valve surgery, 
which provides better surgical exposure of the 
mitral valve with favorable cosmetic results, 
presenting a good option for young female 
patients [9]. However, sternotomy is still the 
most common incision for cardiac surgery, 
including mitral valve surgery, which could be 
attributed to better access to all cardiac 
chambers and great vessels [10]. 
Therefore, the objectives of the present study 
were to evaluate our experience with RALT 
compared to MS for mitral valve replacement and 
to report the postoperative clinical outcome. 
Patients and Methods: 
This prospective cohort study was conducted 
from January 2016 to August 2018 after being 
approved by the local Ethical Committee of 
Research at Assiut University. Informed consent 
was taken from all patients prior to their 
enrolment in the study. 
The inclusion criteria were patients aged >18 
years old and undergoing isolated mitral valve 
replacement. We excluded patients younger than 
18 years old, patients with congenital heart 
disease, concomitant procedure, obesity (BMI > 
30 kg/m2), chest wall deformity, and patients with 
significant pulmonary, renal, hematologic, 
hepatic, endocrine, metabolic or neurologic 
impairment. The study included 40 patients who 
were assigned to two groups: group (I) included 20 
patients who underwent conventional MS 
approach, and group (II) included 20 patients who 
underwent RALT with the complete cannulation 
and aortic cross-clamping conducted through the 
same incision. 
The diagnosis of the mitral valve disease was 
established with transthoracic 2D 
Echocardiography (TTE). The preoperative workup 
included full history taking, clinical examination, 
routine laboratory investigations, chest X-ray, and 
echocardiography.  
For the MS approach, aortic and bi-caval 
cannulation was performed, and mild 
hypothermia (32°C) was used for cardiopulmonary 
bypass. RALT patients were positioned supine with 
the right shoulder elevated 30-50 degrees and the 
right arm at the patient’s side with exposure of 
mid axillary line on the right side. These patients 
were intubated with a dual-lumen endotracheal 
tube or with an endobronchial blocker placed in 
the right mainstem bronchus. A 10-12 cm incision 
in the right sub-mammary fold was made, starting 
3-5 cm from the lateral border of the sternum. 
After mobilization of the breast tissue, the pleural 
cavity was entered through 4th intercostal space. 
Then, the pericardial sac was opened, and the 
pericardium was fixed to the wound edge with 
heavy silk sutures to provide good exposure of the 
ascending aorta. The ascending aorta was 
cannulated using gentle traction to expose the site 
of cannulation. Then, bi-caval cannulation was 
performed, and an aortic cross-clamp was applied 
using a long-curved clamp. Cardioplegia was 
delivered through the aortic root. The left atrium 
was opened through an incision posterior and 
parallel to the interatrial groove that accessed the 
mitral valve. The excision and replacement of the 
mitral valve were performed in the usual manner, 
followed by re-warming, de¬-airing, and closure of 
left atriotomy. De-cannulation was then 
performed, and the suture line secured before 
giving the protamine. The chest was then closed in 
layers leaving one thoracic drain.  
All patients were evaluated thoroughly during 
their intensive care unit (ICU) and hospital stay. 
The collected data included: Aortic cross-clamp 
time, total bypass time, total operative time 
(defined as the time from skin incision to skin 
closure), postoperative blood loss, duration of ICU 
and hospital stay, ICU morbidities, postoperative 
pain score, and any postoperative complication 
including wound infection, and arrhythmias. 
Patients were followed up for 3 months in the 
outpatient clinic for wound sequelae, pain, patient 
satisfaction, and breathlessness.
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Table 1: Preoperative demographic, clinical, and echocardiographic characteristics of studied groups. (Continuous 
variables are presented as mean± SD and categorical variables as number and percent) 
Variable MS (n=20) RALT (n=20) P-value 
Age (years) mean ± SD, range 34.2 ± 5.7 35.3 ± 5.8 0.54 
Sex (M/F) 12 (60%)/8 (40%) 14 (70%)/6 (30%) 0.50 
Body mass index(kg/m2) 23.1 ± 2.74 22.8 ± 2.49 0.71 
NYHA class 2.52 ± 0.61 2.41 ± 0.71 0.60 
Mitral valve lesion: 
Mitral stenosis 10 (50.0%) 11 (55.0 %) 0.75 
Mitral regurgitation 6 (30.0%) 7 (35.0%) 0.73 
Double Mitral lesion 4 (20.0%) 2 (10.0%) 0.37 
EF (%) 61.1 ± 4.92 63.2 ± 5.60 0.21 
LA (cm) 4.91 ± 0.61 5.09 ± 0.54 0.32 
LVED (cm) 4.98 ± 0.81 5.18 ± 0.74 0.42 
LVES (cm) 3.29 ± 0.57 3.47 ± 0.48 0.28 
PAP (mmHg) 39.2 ± 10.8 41.8 ± 9.4 0.42 
MS: Median sternotomy, RALT: Right anterolateral thoracotomy, EF: Ejection fraction, LA: Left atrium, 
LVEDD: left ventricular end-diastolic dimension, LVESD: Left ventricular end-systolic dimension, PAP: 
Pulmonary artery pressure. 
Statistical Analysis 
Statistical analysis was performed using the 
SPSS for Windows version 20, (SPSS Inc., Chicago, 
IL). Quantitative data were expressed as mean ± 
standard deviation, and qualitative data were 
expressed as number and percentage. 
Quantitative continuous variables were analyzed 
using the Student T-test or non-parametric Mann-
Whitney test as appropriate. Comparisons 
between pre and postoperative variables were 
performed with the paired sample T-test. 
Categorical data were analyzed using Chi-square 
or Fisher's exact test. For all statistical 
comparisons, a P-value of <0.05 was considered 
significant.  
Results 
There were no statistically significant 
differences between groups regarding 
and preoperative demographic, clinical, 
echocardiographic characteristics (Table 1). 
Intra- and postoperative outcomes in the 
studied groups are shown in (Table 2), the RALT 
group had a significantly higher cross-clamp time 
and total bypass time compared to the MS group 
(P < 0.01). The mean total operative time was 
significantly higher in the RALT approach 
compared to the MS approach (P < 0.01). 
Ventilation time was significantly higher in the MS 
group (6.1 ± 1.84 h vs. 4.2 ± 1.51 h, P < 0.01).  The 
MS group required a significantly higher amount 
of blood transfusion (2.19 ± 1.1 units vs. 1.41 ± 
0.6 units, P < 0.01). (Table 2) 
Two patients (10.0%) in the MS group required 
re-exploration for bleeding due to excessive blood 
drainage (> 4 ml / Kg/ hour), while no patients 
required re-exploration for bleeding in RALT 
group. In the 1st postoperative day, the RALT 
group had significantly lower pain scores 
compared (7.65 ± 0.56 vs. 9.77 ± 0.61, P < 0.01).  
Ten cases in the MS group (50%) suffered from 
postoperative complications versus 6 cases (30%) 
in the RALT group, with no significant difference 
between the groups.  There was no reported 
mortality. The results demonstrated that the 
mean duration of hospital stay was significantly 
higher in the MS group compared to the RALT 
group (8.4 ± 1.6 vs. 7.2 ± 1.3 days, P= 0.013). 
(Table 2) 
Patient satisfaction was significantly higher 
RALT group compared to MS group; 6 patients 
(30.0%) in the MS group were satisfied with their 
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Table 2: Intra- and postoperative outcomes. Continuous variables are presented as mean± SD and categorical variables 
as number and percent) 
Variable MS (n=20) RALT (n=20) P-value 
Cross Clamp time (min) 45.8 ± 8.7 77.7 ± 16.1 <0.01 
Total Bypass time (min) 72.2 ± 10.4 105.2 ± 12.7 <0.01 
Total operative time (min) 231 ± 36 287 ± 41 <0.01 
Inotropic Support 9 (45.0%) 14 (70.0%) 0.10 
DC Shock 6 (30.0%) 8 (40.0%) 0.50 
Ventilation time (hours) 6.1 ± 1.84 4.2 ± 1.51 <0.01 
Blood loss (ml) 335 ± 137 229 ± 85 <0.01 
Blood transfusion (unit) 2.19 ± 1.1 1.41 ± 0.6 <0.01 
ICU stay (days) 2.78 ± 0.82 2.11 ± 0.49 <0.01 
Re-exploration 2 (10%) 0 0.14 
Hospital stay (days) 8.4 ± 1.6 7.2 ± 1.3 0.01 
Pain scores (1st day)  9.77 ± 0.61 7.65 ± 0.56 <0.01 
Pain scores (2nd day) 7.81 ± 0.53 5.67 ± 0.79 <0.01 
Hypertrophic scar 5 (25%) 2 (10%) 0.21 
Patient wound satisfaction 6 (30%) 19 (95%) <0.01 
Arrhythmias 7 (35%) 4 (20%) 0.28 
Lung atelectasis 0 1 (5%) 0.31 
Superficial wound infection 3 (15%) 1 (5%) 0.29 
Pleural effusion 2 (10%) 3 (15%) 0.63 
Pericardial effusion 4 (20%) 6 (30%) 0.46 
MS: Median sternotomy, RALT: Right anterolateral thoracotomy 
wound, while 19 patients (95.0%) in the RALT 
group were satisfied with their wound (P < 0.01). 
The result of the X-ray findings and 
echocardiography during 3 months after surgery 
in both groups showed that 2 patients (10%) had 
mild pleural effusion in the MS group compared to 
3 patients (15.0%) in the RALT group with no 
statistical significance differences between both 
groups (P=0.63). A small amount of pericardial 
effusion was recorded in 4 cases in the MS group 
versus 6 cases in the RALT group (P=0.46).  
No significant differences were noticed 
between both groups regarding pre and post-
operative echocardiography variables (Table 3). 
Discussion 
In order to reduce the significant risk of 
postoperative infection and dehiscence after the 
MS approach for mitral valve surgery, the RALT 
approach has been suggested as an alternative 
approach with low perioperative morbidity and 
mortality [4, 7]. The aim of this study was to 
evaluate the safety and efficacy of mitral valve 
replacement through a right anterolateral 
thoracotomy and to compare the results of this 
approach with the conventional median 
sternotomy approach. 
The thoracotomy approach is performed 
through a small incision of 10-12 cm in length that 
can improve the cosmetic result due to a small 
scar, which is less visible, especially in females, in 
comparison to a mean length of 25 cm for 
sternotomy approach [5]. El Fiky and colleagues 
[11] reported an incision length of 12–15 cm after 
RALT. Reduction in the size of the operative 
incision was associated with reduced 
postoperative discomfort, shorter ICU and 
hospital stay, earlier recovery and return to work, 
and an overall improvement in patient 
satisfaction [12]. 
The present results showed that the RALT 
group had higher cross-clamp and bypass time 
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compared to the MS group. These results agreed 
with Malik and coworkers [4] who compared 
standard MS with the RALT approach for mitral 
valve replacement. They found that aortic cross-
clamp time was 61± 15 minutes in the MS group 
and 69 ± 12 min in the RALT group. The observed 
cross-clamp time was consistent with other series 
[5, 13]. Moreover, these results agreed with 
those of a systematic review and meta-analysis 
[14]. However, Shah and colleagues [8] found 
that there was a statistically significant difference 
in cross-clamp time was found between the two 
groups, cross-clamp time was 45.3±8.3 minutes in 
the MS group and 41.7±5.7 minutes in the RALT 
group. 
In the present study, ventilation time was 
significantly higher in the RALT group. Similar to 
our findings, Malik and coworker [4] found that 
ventilation time in The MS group was 8.9 ± 0.8 
hours and 6.75 ± 1 hour in the RALT group. In 
addition, these results are in line with other 
authors [11, 15, 16] who found that 
postoperative mechanical ventilation is 
significantly lower in patients undergoing 
thoracotomy for mitral valve surgery, and it may 
be related to less postoperative pain and minimal 
effect on respiratory mechanics. 
The present results demonstrated that the MS 
group required a higher amount of blood 
transfusion compared to the RALT group. A 
reduction in postoperative bleeding and 
transfusion requirements has been suggested as a 
potential advantage of minimally invasive valve 
surgery. This benefit is essential given the 
significant morbidity and mortality associated 
with transfusions and re-exploration for bleeding 
[17, 18]. 
Our results showed that patients of MS group 
had significantly higher ICU stay compared to 
those of the RALT group. It has been reported that 
thoracotomy proved to be superior to sternotomy 
in terms of postoperative ICU stay; this is 
consistent with other studies [5, 13]. The present 
results showed that in 1st and 2nd postoperative 
days, the RALT group had significantly lower pain 
scores compared to the MS group. A reduction in 
pain and faster return to regular activity is the 
most consistent finding of all the potential 
benefits of less invasive approaches [19-22]. 
Moreover, less time was required to return to 
normal activities was noted as an additional 
advantage for the thoracotomy approach [19, 
20]. 
Table 3: Comparison between preoperative and 3 months postoperative trans-thoracic echocardiography in both 
groups (Data are presented as mean and standard deviations) 
Variable MS (n=20) RALT (n=20) P-value (Inter-groups) 
EF % 
Preoperative 61.1 ± 4.9 63.2 ± 5.6 0.21 
3 months postop. 58.7 ± 2.7 60.8 ± 4.2 0.07 
P-value (Intragroup) 0.042 0.09 
LA (cm) 
Preoperative 4.91 ± 0.61 5.09 ± 0.54 0.32 
3 months postop. 4.63 ± 0.41 4.76 ± 0.52 0.38 
P-value (Intragroup) 0.041 0.032 
LVED (cm) 
Preoperative 4.98 ± 0.81 5.18 ± 0.74 0.42 
3 months postop. 4.67 ± 0.55 4.88 ± 0.43 0.18 
P-value (Intragroup) 0.09 0.046 
LVES (cm) 
Preoperative 3.29 ± 0.57 3.47 ± 0.48 0.28 
3 months postop. 2.91 ± 0.24 3.07 ± 0.27 0.06 
P-value (Intragroup) <0.01 <0.01 
PAP (mmHg) 
Preoperative 39.2 ± 10.8 41.8 ± 9.4 0.42 
3 months postop. 34.2 ± 9.2 34.9 ± 7.5 0.81 
P-value (Intragroup) 0.037 <0.01 
MS: Median sternotomy, RALT: Right anterolateral thoracotomy, EF: Ejection fraction, LA: Left atrium, 
LVEDD: left ventricular end-diastolic dimension, LVESD: Left ventricular end-systolic dimension, PAP: 
Pulmonary artery pressure 
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The present results demonstrated that the 
hospital stay was significantly higher in the median 
sternotomy group. Similarly, Malik and coworkers 
[4] found that there was a significant difference 
between groups in the duration of postoperative 
hospital stay, which is consistent with other 
studies [18]. 
Regarding patient satisfaction, the present 
results demonstrated that patient satisfaction was 
significantly higher in the RALT group. In other 
studies, the cosmetic end product of the right 
thoracotomy technique was excellent, especially 
in young females. These features are consistent 
with several studies [23-25]. 
Transthoracic echocardiography parameters 
were significantly decreased at 3 months 
postoperative compared to preoperative values in 
both groups; however, no significant differences 
were noticed between both groups. These results 
are in agreement with many authors [4, 8, 26, 27, 
28]. The changes in left ventricular (LV) 
dimensions reflect the improvement of LV 
geometry and performance after surgery. 
Bleeding and re-exploration were less in the 
RALT group. This may be the result of the smaller 
incision, which lessens the potential for bleeding. 
It is possible to stop bleeding from a minimally 
invasive incision during entry, whereas sternal 
bleeding from a standard sternotomy continues 
throughout the operative procedure [8]. It is 
suspected that a sternotomy will continue to 
bleed into the mediastinum even after it has been 
re-approximated.  
Generally, our contemporary work confirmed 
the advantages of RALT for mitral valve surgery in 
regard to less trauma, less bleeding, less wound 
infections, less pain, favorable cosmesis, faster 
recovery, and shorter hospital length of stay. 
Study limitations 
The study has several limitations, including 
small patients’ numbers and lack of 
randomization. Several risk factors are unequally 
distributed between groups and may have 
affected the outcomes.  Additionally, this is a 
single-center experience, and generalization of 
the results may not be feasible. Finally, the follow-
up period is short, and longer follow-up is 
recommended. 
Conclusion 
The RALT approach for mitral valve surgery 
was associated with good exposure of the mitral 
valve. This approach may be associated with less 
blood loss, and transfusion, shorter ICU and 
hospital stay, and better patients’ satisfaction. 
RALT may be recommended as an alternative to 
standard median sternotomy for patients 
undergoing mitral valve replacement. 
Conflict of interest: Authors declare no conflict of 
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